Clinical Trials Browser

OTHER × Antibodies, Monoclonal × Lymphoid × Clear all

NCT06550141 2025-11-14

Emapalumab Prevention of CAR-T Cell Associated Toxicities

Phase 2 Recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT06796517 2025-01-28

Immunotherapy in Lymphoma

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT05073250 2023-05-12

IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT00989586 2017-02-06

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Phase 1/2 Completed

35 enrolled 11 charts

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00142155 2011-06-27

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Phase NA Completed

Waldenstrom Macroglobulinemia

NCT00515892 2007-08-14

NHL

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin